LUNG-TRANSPLANT RECIPIENTS

Clinical trials for LUNG-TRANSPLANT RECIPIENTS explained in plain language.

Never miss a new study

Get alerted when new LUNG-TRANSPLANT RECIPIENTS trials appear

Sign up with your email to follow new studies for LUNG-TRANSPLANT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope to halt deadly transplant rejection

Disease control Completed

This study tested whether the drug nintedanib could slow the decline in lung function for people who developed a serious complication called bronchiolitis obliterans syndrome (BOS) after a lung transplant. In this Phase 3 trial, 58 transplant recipients with early to moderate BOS…

Matched conditions: LUNG-TRANSPLANT RECIPIENTS

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

LUNG-TRANSPLANT RECIPIENTS

Get alerted when new LUNG-TRANSPLANT RECIPIENTS trials appear

New hope to halt deadly transplant rejection